685 related articles for article (PubMed ID: 24985397)
41. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.
Lefrançais E; Duval A; Mirey E; Roga S; Espinosa E; Cayrol C; Girard JP
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15502-7. PubMed ID: 25313073
[TBL] [Abstract][Full Text] [Related]
42. Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion.
Luzina IG; Lockatell V; Courneya JP; Mei Z; Fishelevich R; Kopach P; Pickering EM; Kang PH; Krupnick AS; Todd NW; Vogel SN; Atamas SP
Cell Immunol; 2023 Jan; 383():104657. PubMed ID: 36603504
[TBL] [Abstract][Full Text] [Related]
43. IL-33 exacerbates eosinophil-mediated airway inflammation.
Stolarski B; Kurowska-Stolarska M; Kewin P; Xu D; Liew FY
J Immunol; 2010 Sep; 185(6):3472-80. PubMed ID: 20693421
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury.
Mato N; Fujii M; Hakamata Y; Kobayashi E; Sato A; Hayakawa M; Ohto-Ozaki H; Bando M; Ohno S; Tominaga S; Sugiyama Y
Eur Respir J; 2009 Jun; 33(6):1415-28. PubMed ID: 19196821
[TBL] [Abstract][Full Text] [Related]
45. IL-33/ST2 axis promotes mast cell survival via BCLXL.
Wang JX; Kaieda S; Ameri S; Fishgal N; Dwyer D; Dellinger A; Kepley CL; Gurish MF; Nigrovic PA
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10281-6. PubMed ID: 24982172
[TBL] [Abstract][Full Text] [Related]
46. IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation.
Dong Z; Lu X; Yang Y; Zhang T; Li Y; Chai Y; Lei W; Li C; Ai L; Tai W
BMC Pulm Med; 2015 Feb; 15():13. PubMed ID: 25888222
[TBL] [Abstract][Full Text] [Related]
47. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.
Kim JH; Kim HY; Kim S; Chung JH; Park WS; Chung DH
Am J Pathol; 2005 Nov; 167(5):1231-41. PubMed ID: 16251408
[TBL] [Abstract][Full Text] [Related]
48. The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.
Hong K; Lee Y; Lee S; Hong S; Bae S; Hong J; Choi J; Jhun H; Kwak A; Kim E; Jo S; Kang T; Cho YS; Kim YG; Kim S
Immunol Res; 2013 May; 56(1):122-30. PubMed ID: 23435764
[TBL] [Abstract][Full Text] [Related]
49. Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts.
Kurokawa M; Matsukura S; Kawaguchi M; Ieki K; Suzuki S; Odaka M; Watanabe S; Homma T; Sato M; Yamaguchi M; Takeuchi H; Adachi M
Int Arch Allergy Immunol; 2011; 155 Suppl 1():12-20. PubMed ID: 21646790
[TBL] [Abstract][Full Text] [Related]
50. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
51. Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages.
Zhao J; Okamoto Y; Asano Y; Ishimaru K; Aki S; Yoshioka K; Takuwa N; Wada T; Inagaki Y; Takahashi C; Nishiuchi T; Takuwa Y
PLoS One; 2018; 13(5):e0197604. PubMed ID: 29782549
[TBL] [Abstract][Full Text] [Related]
52. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
53. The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice.
Tabata C; Tabata R; Nakano T
Clin Exp Immunol; 2010 Dec; 162(3):560-7. PubMed ID: 20846163
[TBL] [Abstract][Full Text] [Related]
54. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
55. Akt1 regulates pulmonary fibrosis via modulating IL-13 expression in macrophages.
Nie Y; Hu Y; Yu K; Zhang D; Shi Y; Li Y; Sun L; Qian F
Innate Immun; 2019 Oct; 25(7):451-461. PubMed ID: 31299858
[TBL] [Abstract][Full Text] [Related]
56. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms.
Mi S; Li Z; Yang HZ; Liu H; Wang JP; Ma YG; Wang XX; Liu HZ; Sun W; Hu ZW
J Immunol; 2011 Sep; 187(6):3003-14. PubMed ID: 21841134
[TBL] [Abstract][Full Text] [Related]
57. The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin.
Fanny M; Nascimento M; Baron L; Schricke C; Maillet I; Akbal M; Riteau N; Le Bert M; Quesniaux V; Ryffel B; Gombault A; Même S; Même W; Couillin I
Front Immunol; 2018; 9():1476. PubMed ID: 29988569
[TBL] [Abstract][Full Text] [Related]
58. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
59. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
60. IL-33-activated dendritic cells are critical for allergic airway inflammation.
Besnard AG; Togbe D; Guillou N; Erard F; Quesniaux V; Ryffel B
Eur J Immunol; 2011 Jun; 41(6):1675-86. PubMed ID: 21469105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
